Sat. Oct 23rd, 2021

Growing prevalence of MRSA infection worldwide will drive the global MRSA testing market, finds Fortune Business Insights in its report, titled “MRSA Testing Market Size, Share and Global Trend By Test Type (Molecular Diagnostic Tests, Immunodiagnostic Tests), By End User (Hospitals, Diagnostic & Pathology Centers, Research Institutes, Others), and Geography Forecast till 2026”. A comprehensive analysis of the expected market trends and crucial factors is also incorporated in the report.

Get Sample PDF

Top Leaders Overview:

Some of the leading companies in the global MRSA Testing Market are

  • Abbott
  • Hain Lifescience
  • 3M
  • Alifax Holding S.p.A.
  • Creative Diagnostics
  • ZeptoMetrix Corporation
  • Cepheid
  • Abacus Diagnostica Oy
  • Diatherix
  • Puritan Medical Products co
  • Luminex Corporation

Methicillin-resistant Staphylococcus aureus, or simply, MRSA, is a highly contagious bacterial infection caused by Staphylococcus or ‘staph’bacteria. A person generally catches the infection through a break or cut in the skin and can be easily treated through antibiotics. These infections are usually hospital-acquired or community-acquired. People who have been recently hospitalized, are undergoing haemodialysis, live in a nursing home, have weak immunity, share exercise equipment, or work in unsanitary conditions are most likely to contract the MRSA infection.

Ask for Customization

Increasing Rate of Community-Acquired MRSA Infection to Drive the Market

The global MRSA testing market growth is likely to be spurred by the growing incidence of community-acquired MRSA infection. According to the CDC’s National Healthcare Safety Network, in 2015, of all the MRSA infections reported, 83.2% were of the community-acquired type. Moreover, the Centre for Disease Control and Prevention also estimates a rise in hospital-acquired staph infection by 7% per year in the US. This will provide a major thrust to the global MRSA testing market size as the infection becoming more widespread will broaden the market base and encourage public and private investment to contain the infection.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Please Visit: https://www.fortunebusinessinsights.com/industry-reports/mrsa-testing-market-100699

Advancements in Molecular Testing Techniques to Fuel Market Growth

Sophistication in molecular-based diagnostic techniques for MRSA is expected the drive the global MRSA testing market during the forecast period. Molecular testing allows for shorter time periods to detect MRSA infection as these techniques are rapid and sensitive. Furthermore, these methods reduce treatment costs and aid in containing the spread of infection. The global MRSA testing market stands to benefit from the multiple advantages of advanced molecular diagnostic techniques for MRSA.

The only inhibiting factor in the global MRSA testing market is the high sensitivity of molecular assays, as, according to the CDC, the assay may not be able to exclude the possibility of infections such as influenza.

Innovation Opportunities Being Lapped Up by Competitors

Key participants are adopting various strategies, such as increasing investment in innovation, to bolster their position, catalysing the global MRSA testing market expansion. For example, in 2018, ZeptoMatrix launched new streptococcal molecular quality controls, NATtrol GBS Positive Control and NATtrol GBS Negative Control, to treat bacterial infections including MRSA. Big companies are also acquiring other smaller companies to diversify their product portfolios. For instance, Alere was taken over by Abbott in 2017, resulting in Abbott getting control of Alere’s diagnostic kits and other products. These moves are expected to make the market competition for MRSA testing dynamic.

Related Reports:

Teleradiology Market Segments

Teleradiology Market Competitive Landscape

Teleradiology Market Demand

Teleradiology Market Key Players

Teleradiology Market Business Opportunities

Teleradiology Market Analysis

Teleradiology Market Growth

Teleradiology Market Trends

Teleradiology Market Share

Teleradiology Market Size

By umang.s

Leave a Reply

Your email address will not be published. Required fields are marked *